FDA Fast-Tracks Good Trip With Approved Psychedelic Drugs For Depression

The vouchers cut down the FDA review process from 12 months to one to two months, making psychedelics potentially available ...
Scientific American

RFK, Jr., puts psychedelics on fast track to FDA review and approval

The U.S. Food and Drug Administration is seeking to accelerate the review process for three companies that are studying ...

FDA moves to fast-track review of psilocybin and methylone for mental health

Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental ...
Devdiscourse

FDA Transparency Under Scrutiny Amid Drug Approval Processes

The U.S. FDA's accelerated drug approval process requires greater transparency, states the Institute for Clinical and ...
Regulatory Affairs Professionals Society

FDA finds most postmarketing requirements, commitments progressing on schedule

Most drug and biological manufacturers met their postmarketing requirements (PMR) and postmarketing commitments (PMC) during ...